InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-43.1%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Deluccia Robert J, 董事. Officer active across 1 company, notably Acurx Pharmaceuticals, Inc.. Aggregated, 4 reports have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €144k. Activity tracked since 19 November 2021. The latest transaction was filed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Deluccia Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
49,261 股@ US$1.01529.3% 占其流量Common StockSEC:0001104659-25-002050:0
标准退出：2025年4月6日 (T+90)
40,000 股0Common StockSEC:0001104659-24-001375:0
19,737 股@ US$3.8044.4% 占其流量Common StockSEC:0001104659-22-084316:0
标准退出：2022年10月25日 (T+90)
5,034 股@ US$4.90115.1% 占其流量Common StockSEC:0001104659-21-142473:0
标准退出：2022年2月17日 (T+90)
4 条申报中的 4 条
About Deluccia Robert J
Robert J. DeLuccia is a Director at Acurx Pharmaceuticals, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. Robert is involved in key decisions that influence the future of Acurx Pharmaceuticals.
